期刊文献+

53例多发性骨髓瘤的分子遗传学研究 被引量:1

原文传递
导出
摘要 目的:研究多发性骨髓瘤(MM)分子遗传学情况。方法运用荧光原位杂交技术(FISH)对53例多发性骨髓瘤患者进行遗传学分析,检测患者13q14缺失、14q32易位、p53缺失、1q21扩增等异常情况。结果53例患者中,FISH 法检测出染色体异常45例(84.9%),其中IgH基因重排20例(37.7%),p53缺失10例(18.9%),1q21基因扩增19例(35.8%),13q14缺失27例(50.9%)。结论FISH 法能大大提高多发性骨髓瘤患者染色体异常的检出率,同时多发性骨髓瘤患者13q14缺失和1q21异常之间存在高度相关性。
作者 刘云 钱同胜
出处 《徐州医学院学报》 CAS 2015年第8期521-523,共3页 Acta Academiae Medicinae Xuzhou
  • 相关文献

参考文献6

  • 1Chang H, Qi C, Yi QL, et al. p53 gene deletion detected by fluo- rescence in situ hybridization is an adverse prognostic factor for pa- tients with multiple myeloma following autologous stem cell trans- plantation [J].Blood, 2005,105 ( 1 ) : 358 - 360.
  • 2Fonseea R, Van Wier SA, Chng WJ, et al. Prognostic value of chromosome 1 q21 gain by fluorescent in situ hybridization and in- crease CKS1B expression in myeloma [ J]. Leukemia, 2006,20 ( 11 ) : 2034 - 2040.
  • 3Wu KL, Beverloo B, Lokhorst HM, et al. Abnormalities of chro- mosome lp/q are highly associated with chromosome 13/13q dele- tions and are an adverse prognostic factor for the outcome of high - dose chemotherapy in patients with multiple myeloma [ J ]. Br J Haematol, 2007,136(4) :615 -623.
  • 4陈丽娟,李建勇,朱雨,王晓炜,仇海荣,杨瑞芳,徐卫,许家仁,陆化.多发性骨髓瘤1q染色体异常与13q缺失的相关性研究[J].中华医学遗传学杂志,2009,26(1):102-105. 被引量:13
  • 5Chang H, Yeung J, Qi C,et al. Aberrant nuclear p53 protein ex- pression detected by immunohistochemistry is associated with hemi- zygous P53 deletion and poor survival for multiple myeloma [ J ]. Br J Haematol, 2007,138(3) :324 -329.
  • 6Fonseca R, Bailey RJ, Ahmann GJ, et al. Genomic abnormalities in monoctonal gammopathy of undetermined significance [ J ]. Blood, 2002,100(4) :1417 - 1424.

二级参考文献17

  • 1Chang H, Li D, Zhuang L, et al. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis. Leule Lymphoma, 2004, 45 : 965 -969.
  • 2Pantou D, Rizou H, Tsarouha H, et al. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes Chromosomes Cancer, 2005, 42: 44-57.
  • 3Chang H, Sloan S, Li D, et al. Multiple myeloma involving central nervous system: high frequency of chromosome 17p13. 1 (p53) deletions. BrJ Haematol, 2004, 127 : 280-284.
  • 4Gonzalez MB, Hernandez JM, Garcia JL, et al. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma. Haernatologica, 2004, 89:1213-1218.
  • 5Greipp PR, San Miguel J, Durie BG, etal. International staging system for multiple myeloma. J Clin Oncol, 2005, 23 : 3412- 3420.
  • 6Debes-Marun CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia, 2003,17 :427-436.
  • 7Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood, 2002, 99 : 2185-2191.
  • 8Fiserova A, Hajek R, Holubova V, et al. Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells. Neoplasma, 2002,49 : 300 -306.
  • 9Fonseca R, Harrington D, Oken MM, et al. Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (A13) in multiple myeloma: an eastern cooperative oncology group study. CancerRes, 2002, 62 : 715 -720.
  • 10Fonseca R, Oken MM, Harrington D, et al. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy. Leukemia,2001, 15 : 981-986.

共引文献12

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部